Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02990000 · ClinicalTrials.gov registry record · NA

Enhancing Mental Health Care by Scientifically Matching Patients to Providers' Strengths

A NA study of Mental Illness, sponsored by University of Massachusetts, Amherst.

Completed
Registry status
NA
Development phase
288
Enrollment target
1
Study location

NCT02990000: Completed NA study of Mental Illness, sponsored by University of Massachusetts, Amherst.

NCT02990000 is a NA study of Mental Illness that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 288 participants, above the 169-participant average among 11 other Mental Illness trials with a reported enrollment target (70% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02990000, a NA study of Mental Illness, has completed, sponsored by University of Massachusetts, Amherst.

COMPLETED
Registry status
NA
Development phase
288 participants
Enrollment target
1
Study location

Study Summary

Research has shown that mental health care (MHC) providers differ significantly in their ability to help patients. In addition, providers demonstrate different patterns of effectiveness across symptom and functioning domains. For example, some providers are reliably effective in treating numerous patients and problem domains, others are reliably effective in some domains (e.g., depression, substance abuse) yet appear to struggle in others (e.g., anxiety, social functioning), and some are reliably ineffective, or even harmful, across patients and domains. Knowledge of these provider differences is based largely on patient-reported outcomes collected in routine MHC settings. Unfortunately, provider performance information is not systematically used to refer or assign a particular patient to a scientifically based best-matched provider. MHC systems continue to rely on random or purely pragmatic case assignment and referral, which significantly "waters down" the odds of a patient being assigned/referred to a high performing provider in the patient's area(s) of need, and increases the risk of being assigned/referred to a provider who may have a track record of ineffectiveness. This research aims to solve the existing non-patient-centered provider-matching problem. Specifically, the investigators aim to demonstrate the comparative effectiveness of a scientifically-based patient-provider match system compared to status quo pragmatic case assignment. The investigators expect in the scientific match group significantly better treatment outcomes (e.g., symptoms, quality of life) and higher patient satisfaction with treatment. The investigators also expect to demonstrate feasibility of implementing a scientific match process in a community MHC system and broad dissemination of the easily replicated scientific match technology in diverse health care settings. The importance of this work for patients cannot be understated. Far too many patients struggle to find the right provi

Primary Outcome

The TOP-Clinical Scales consist of 58 items assessing 12 symptom and functional domains (risk-adjusted for case mix variables assessed via 37 items on the companion TOP-Case Mix form, such as divorce, job loss, comorbidity): work functioning, sexual functioning, social conflict, depression, panic/somatic anxiety, psychosis, suicidal ideation, violence, mania, sleep, substance abuse, and quality of life. Global symptom severity was assessed by averaging the z-scores (i.e., standard deviation unit

Conditions Studied

Interventions

  • BEHAVIORAL Scientific Match

Study Locations (1)

Massachusetts

  • University of Massachusetts Amherst - Amherst

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2017-11-06
Est. Completion 2020-03-15
Phase NA

What the finished NCT02990000 record still lists

NCT02990000 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, above the 169-participant average among 11 other Mental Illness trials with a reported enrollment target (70% higher).

The record links to 1 condition, with Mental Illness appearing as the primary indexed condition, and to 1 intervention - of which Scientific Match is the first listed.

NCT02990000 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02990000 about?

NCT02990000 is a clinical study titled "Enhancing Mental Health Care by Scientifically Matching Patients to Providers' Strengths". Research has shown that mental health care (MHC) providers differ significantly in their ability to help patients. In addition, providers demonstrate different patterns of effectiveness across symptom and functioning domains. For example, some providers are reliably effective in treating numerous pa...

What is the current status of trial NCT02990000?

This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2017-11-06. Estimated completion is 2020-03-15.

What conditions does trial NCT02990000 study?

This clinical trial studies the following conditions: Mental Illness.

What interventions are being tested in trial NCT02990000?

The interventions under investigation include: Scientific Match (BEHAVIORAL).

Who is sponsoring clinical trial NCT02990000?

This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02990000 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02990000's enrollment target sits among peer trials

288 2nd of 11 the highest of 11 other Mental Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02098265 · 288 participants · NA

    A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

  • NCT03741777 · 288 participants · NA

    Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume

  • NCT03937635 · 288 participants · Phase 3

    Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • NCT04621877 · 288 participants · NA

    Lay-Delivered Behavioral Activation in Senior Centers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02990000, the US trial registry maintained by the National Library of Medicine. NCT02990000 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.